Clinical Trial Update: sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating selective serotonin reuptake inhibitors for Post-COVID conditions; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection
• Post-covid-19 Condition

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Post-COVID, POST-Covid 19 | Phase 3 | Status: NOT_YET_RECRUITING